ITPC Announces the Formation of ITPC Latin America and the Caribbean (ITPC LATCA)

The International Treatment Preparedness Coalition (ITPC) is proud to announce the merging of its Latin American and Caribbean treatment access networks to form the “International Treatment Preparedness Coalition – Latin America and Caribbean” (ITPC LATCA). This joint network will strengthen the community HIV treatment access movement in both Latin America and the Caribbean and amplify […]

ITPC West Africa Press Release: “Ebola is Major Factor Interrupting Antiretroviral Treatment to People Living with HIV in Sierra Leone”

MAY 29TH, 2015. FOR IMMEDIATE RELEASE  Today, human rights campaigners call for improved and regular access to HIV treatment in Sierra Leone, following the Ebola crisis. The International Treatment Preparedness Coalition – West Africa (ITPC-WA) joined forces with The Network of HIV Positives in Sierra-Leone to survey people living with HIV. They found that the […]

ITPC Welcomes Evidence for Early Start to HIV Treatment

The International Treatment Preparedness Coalition (ITPC) welcomes encouraging new evidence from an international study, Strategic Timing of AntiRetroviral Treatment, or START for short. “It is exciting to see that we now have data that provides concrete evidence of the clinical benefits of starting people early on HIV treatment,” explains Christine Stegling, Executive Director of ITPC. […]

Activists in Ukraine hold critical roundtable on patent barriers on medicines

On April 15, 2015, the All-Ukrainian Network of People Living with HIV and AIDS convened a roundtable meeting titled Patent Barriers on Medicines: Potential Opportunities to Overcome the Barriers. The meeting brought together representatives of Indian and Ukrainian generic manufacturers in order to identify opportunities to overcome patent barriers through the use of compulsory licensing, […]

Thousands of activists urge company to change its policies on eve of shareholder meeting

New York, May 5, 2015 — On the eve of pharmaceutical company Gilead Sciences’ annual shareholder meeting, thousands of people who have hepatitis C virus (HCV) and HCV/HIV coinfection, with their allies and physicians, have demanded that Gilead change its policies that deny access to treatment for millions of people in developing countries. “Gilead must […]

Civil Society Opposes Patent Application on HIV Drug Truvada® In a Bid to Stop Argentina From Paying 30 Times More Than Other Countries

The International Treatment Preparedness Coalition (ITPC) supports the patent pre-grant opposition that was filed on 13 April 2015 by the Fundación Grupo Efecto Positivo (FGEP) and the Argentinian Network of Positive People (Redar Positive). The patent was filed at Argentina’s patent office and challenges the validity of a patent application submitted by Gilead Sciences on […]

ACT Toolkit

ACT Toolkit launches in English, French, Russian and Spanish

On Human Rights Day, the International Treatment Preparedness Coalition (ITPC) is proud to announce that our Advocacy for Community Treatment (ACT) Toolkit  is now available in English, French, Spanish and Russian. The ACT Toolkit facilitates community activists to become effective advocates for HIV treatment access. It includes a special focus on supporting key populations and ensuring everyone’s right to health is respected.


ITPC and ARASA Host Advocacy Workshop on Global Fund Resources and Sustainable Funding for HIV & TB in Botswana, Malawi and Tanzania

On 9-13 March 2015, ITPC, in collaboration with the Aids and Rights Alliance for Southern Africa (ARASA), facilitated an HIV and TB financing activist workshop aimed at strengthening key population advocacy for the best use of Global Fund resources and sustainable funding for HIV & TB in Botswana, Malawi and Tanzania. The meeting brought together […]